Soft Tissue Cancer
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study Of Naxitamab , Granulocyte Macrophage Colony Stimulating Factor For Patients With Relapsed /Refractory , Soft Tissue or Anti GD2 Immunotherapy Refractory Neuroblastoma (NCT06438614) | Fundació Sant Joan de Déu | 2020-08-20 |
| Project HERO: Health Empowerment & Recovery Outcomes (NCT03345563) | Rutgers, The State University of New Jersey | 2017-07-31 |
Track Soft Tissue Cancer automatically
Every clearance here is in the API, with alerts when new ones post.